Description
Trade name:
Emetrex
Compound:
Each tablet contains:
Cyclizine hydrochloride 50 mg.
Vit B6 (pyridoxine hydrochloride) 30 mg.
Auxiliary components:
Lactose monohydrate, Avicel PH 102, povidone XL (crospovidone), PVPK30, Aerosil 200, purified talc, magnesium stearate, indigo carmine (E132).
Properties:
Emetrex is an antiemetic. Pyridoxine, a water-soluble vitamin, is involved primarily in amino acid metabolism, but is also involved in carbohydrate and fat metabolism, and is necessary for the formation of hemoglobin.
Indications:
For the prevention and treatment of nausea, vomiting or dizziness associated with motion sickness.
Method of administration and dosage:
Adults and children over 12 years of age: 1 tablet every 4-6 hours, no more than 4 tablets within 24 hours.
Children 6 to 12 years old: 1/2 tablet every 6-8 hours, no more than 1.5 tablets in 24 hours.
Contraindications:
Children under 6 years of age; hypersensitivity to the components of the drug; patients with rare hereditary problems of galactose intolerance, Lapp-Lapp deficiency or glucose-galactose malabsorption; pregnancy and lactation.
Precautions:
Do not exceed the recommended dosage. Tell your doctor or pharmacist if you have breathing problems such as emphysema or chronic bronchitis, glaucoma, difficulty urinating due to prostate enlargement. Before use, consult your doctor if you are taking sedatives or tranquilizers. You may feel drowsy, avoid drinking alcohol, sedatives and tranquilizers, as they may increase the effect of drowsiness. Be careful when driving a car or operating machinery.
Side effects:
Hepatic dysfunction, hypersensitivity hepatitis, cholestatic jaundice and cholestatic hepatitis have occurred in association with cyclizine, hypersensitivity reactions including anaphylaxis, muscle spasm.
Central nervous system effects have been reported with cyclizine use, including somnolence, headache, dystonia, dyskinesia, extrapyramidal movement disorders, tremor, seizures, dizziness, decreased consciousness, transient speech disorders, paresthesia, and generalized chorea.
Disorientation, restlessness, nervousness, insomnia, and auditory and visual hallucinations have been reported, especially when dosage recommendations have been exceeded.
Urinary retention, bronchospasm, apnea, urticaria, drug rash, angioedema, allergic skin reactions, and fixed rash are also possible.
Storage method:
Store at a temperature not exceeding 30 degrees in a dry place out of reach of children.
